BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2204139)

  • 1. [The efficacy of immunomodulating therapy in rheumatoid arthritis].
    Bassam B; Balabanova RM
    Ter Arkh; 1990; 62(5):32-5. PubMed ID: 2204139
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined immunomodulating therapy in rheumatoid arthritis].
    Oliunin IuA; Balabanova RM
    Ter Arkh; 1996; 68(5):13-6. PubMed ID: 9082588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomodulating therapy of rheumatoid arthritis].
    Balabanova RM; Barakat B
    Revmatologiia (Mosk); 1990; (3):38-44. PubMed ID: 2151541
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of the effectiveness of immunomodulating preparations in combined therapy of chronic obstructive bronchitis].
    Shilov VA; ShirinskiÄ­ VS
    Klin Med (Mosk); 1995; 73(4):88-90. PubMed ID: 7474838
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of T-activin in viral myocarditis in animal experiments].
    Kipshidze NN; Dzhaparidze MM; Bulusashvili RV; Khuchua AV; Zbiadadze NA
    Biull Eksp Biol Med; 1988 Jun; 105(6):705-7. PubMed ID: 3260519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
    Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
    Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of T-activin and irradiation with a helium-neon laser on the status of the interleukin-2-dependent component of the proliferative response of mononuclear cells in rheumatoid arthritis].
    Parnes EIa; Alikhanov BA; Tkomachev IuK; Muromtsev AV
    Fiziol Cheloveka; 1995; 21(4):143-9. PubMed ID: 7589960
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI; Arion VIa; Petunina NA
    Sov Med; 1987; (12):32-5. PubMed ID: 3502197
    [No Abstract]   [Full Text] [Related]  

  • 9. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
    Shafer NP
    Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the efficacy of topical and subcutaneous administration of tactivin for correcting secondary immunodeficiencies of young children].
    Arion VIa; Bekman EM; Tiurin NA; Mazurina NA; Filimonova AV
    Biull Eksp Biol Med; 1994 Nov; 118(11):496-8. PubMed ID: 7888649
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunocorrection with T-activin in the combined treatment of juvenile rheumatoid arthritis].
    Melikhova NI; Kuz'mina NN; Chirkin VV; Arion VIa; Baryshkov IuA
    Revmatologiia (Mosk); 1987; (3):19-23. PubMed ID: 3317708
    [No Abstract]   [Full Text] [Related]  

  • 12. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Strand V; Tugwell P; Bombardier C; Maetzel A; Crawford B; Dorrier C; Thompson A; Wells G
    Arthritis Rheum; 1999 Sep; 42(9):1870-8. PubMed ID: 10513801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of the immune status of patients with mycosis of the feet and concomitant eczema during T-activin therapy].
    IutskovskiÄ­ AD; Fedotov VP; Leshchenko GM
    Vestn Dermatol Venerol; 1986; (7):17-21. PubMed ID: 3765804
    [No Abstract]   [Full Text] [Related]  

  • 14. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model.
    Wolfe F; Caplan L; Michaud K
    J Rheumatol; 2004 Dec; 31(12):2317-9. PubMed ID: 15570626
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methotrexate and folates in rheumatoid arthritis].
    Endresen GK; Husby G
    Tidsskr Nor Laegeforen; 1999 Feb; 119(4):534-7. PubMed ID: 10081378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methotrexate in the treatment of rheumatoid arthritis].
    Agadzhanian GN; Balabanova RM
    Ter Arkh; 1986; 58(7):114-6. PubMed ID: 3532399
    [No Abstract]   [Full Text] [Related]  

  • 19. Application-dependent immunomodulating and antimetastatic efficacy of thymic peptides in BALB/c-mice.
    Beuth J; Schierholz JM; Ko HL; Braun JM
    In Vivo; 2001; 15(5):403-6. PubMed ID: 11695237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.